Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Didrik Frimann Vestrheim"'
Autor:
Andrew D. Oxman, Atle Fretheim, Simon Lewin, Signe Flottorp, Claire Glenton, Arnfinn Helleve, Didrik Frimann Vestrheim, Bjørn Gunnar Iversen, Sarah E. Rosenbaum
Publikováno v:
Health Research Policy and Systems, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract Much health communication during the COVID-19 pandemic has been designed to persuade people more than to inform them. For example, messages like “masks save lives” are intended to compel people to wear face masks, not to enable them to m
Externí odkaz:
https://doaj.org/article/010b7a6aae594740971d98cb9ee755aa
Autor:
Liv Solvår Nymark, Jacob Dag Berild, Trude Marie Lyngstad, Brita Askeland Winje, Didrik Frimann Vestrheim, Ingeborg Aaberge, Lene Kristine Juvet, Ellen Wolff
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
The aim of this study was to establish whether a universal pneumococcal vaccination for older adults in Norway is likely to be cost-effective from the perspective of the health care provider. A decision tree model developed by the Public Health Agenc
Externí odkaz:
https://doaj.org/article/208a97524d7f4b5f9af2de55f553f77f
Autor:
Guy Berbers, Pieter van Gageldonk, Jan van de Kassteele, Ursula Wiedermann, Isabelle Desombere, Tine Dalby, Julie Toubiana, Sotirios Tsiodras, Ildikó Paluska Ferencz, Kathryn Mullan, Algirdas Griskevicius, Tatjana Kolupajeva, Didrik Frimann Vestrheim, Paula Palminha, Odette Popovici, Lena Wehlin, Tamara Kastrin, Lucia Maďarová, Helen Campbell, Csaba Ködmön, Sabrina Bacci, Alex-Mikael Barkoff, Qiushui He, the Serosurveillance Study Team
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Recent outbreaks of pertussis have highlighted the importance of surveillance of vaccine-preventable diseases. Here, the authors performed a cross-sectional seroprevalence study of pertussis, diphtheria, and tetanus in Europe and found evidence of ci
Externí odkaz:
https://doaj.org/article/479e7bb789a4406a909a0dc159c08fd2
Autor:
Hans Kristian Floeystad, Jacob Dag Berild, Bjoern Jardar Brandsaeter, Didrik Frimann Vestrheim, Dag Berild, Are Martin Holm
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background The study aimed to assess whether gastrointestinal (GI) symptoms at admission are associated with increased short-term mortality in patients with invasive pneumococcal disease (IPD). Methods We included all patients with IPD at Ak
Externí odkaz:
https://doaj.org/article/dc651a3833dc41c29c57f64e6c2464fc
Publikováno v:
Microorganisms, Vol 9, Iss 8, p 1774 (2021)
The elderly and adults with medical risk conditions remain at high risk of invasive pneumococcal disease (IPD), highlighting the importance of adequate preventive efforts. In an observational population-based study in Norway (pop ≥ 5 years, 2009–
Externí odkaz:
https://doaj.org/article/86a8798a0f474d89a473200cdf152bf5
Autor:
Emily MacDonald, Didrik Frimann Vestrheim, Richard A White, Kirstin Konsmo, Heidi Lange, Audun Aase, Karin Nygård, Pawel Stefanoff, Ingeborg Aaberge, Line Vold
Publikováno v:
BMC Public Health, Vol 16, Iss 1, Pp 1-11 (2016)
Abstract Background The approach to surveillance of Lyme borreliosis varies between countries, depending on the purpose of the surveillance system and the notification criteria used, which prevents direct comparison of national data. In Norway, Lyme
Externí odkaz:
https://doaj.org/article/35996cc636fb4625be039f28ba24a523
Autor:
Jacob Dag Berild, Brita Askeland Winje, Didrik Frimann Vestrheim, Hans-Christian Slotved, Palle Valentiner-Branth, Adam Roth, Jann Storsäter
Publikováno v:
Pathogens, Vol 9, Iss 4, p 259 (2020)
Adult vaccination is high on the agenda in many countries. Two different vaccines are available for the prevention of pneumococcal disease in adults: a 23-valent polysaccharide vaccine (PPV23), and a 13-valent conjugated vaccine (PCV13). The objectiv
Externí odkaz:
https://doaj.org/article/a95a8342b96b4882b96e82cb5a4d9094
Autor:
Elina Seppälä, Anja Bråthen Kristoffersen, Håkon Bøås, Didrik Frimann Vestrheim, Margrethe Greve-Isdahl, Birgitte Freiesleben De Blasio, Anneke Steens
Publikováno v:
Vaccine
The acellular pertussis vaccine has been used in the Norwegian national immunisation program since 1998. Following an increase in pertussis incidence in all age groups, booster doses were introduced for 7-8-year-olds in 2006, and for 15-16-year-olds
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::384d57a37dde6b4565a1dd1065a7cba1
https://hdl.handle.net/11250/3007686
https://hdl.handle.net/11250/3007686
Autor:
Guy Berbers, Pieter van Gageldonk, Jan van de Kassteele, Ursula Wiedermann, Isabelle Desombere, Tine Dalby, Julie Toubiana, Sotirios Tsiodras, Ildiko Paluska Ferencz, Kathryn Mullan, Algirdas Griskevicius, Tatjana Kolupajeva, Didrik Frimann Vestrheim, Paula Palminha, Odette Popovici, Lena Wehlin, Tamara Kastrin, Lucia Maďarová, Helen Campbell, Csaba Ködmön, Sabrina Bacci, Alex-Mikael Barkoff, Qiushui He
Reported incidence of pertussis in member states of the European Union (EU) and the European Economic Area (EEA) varies and may not reflect the real situation. In the EU/EEA, vaccine-induced protection against diphtheria and tetanus seems sufficient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a51c9bfd6edf55fed0b036bde0f5dfc
https://doi.org/10.21203/rs.3.rs-35858/v1
https://doi.org/10.21203/rs.3.rs-35858/v1
Publikováno v:
Ticks and Tick-borne Diseases. 7:698-702
Detection of specific antibodies against Borrelia burgdorferi sensu lato is a useful aid for the diagnosis of Lyme borreliosis. However, antibodies are present in the general population. The seroprevalence increase with age, and varies according to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cba0ad5a001033e129e01957616d04e0
https://doi.org/10.1016/j.ttbdis.2016.02.020
https://doi.org/10.1016/j.ttbdis.2016.02.020